Medical Research

Lilly cancels trials for experimental MS drug

July 28, 2009
J.K. Wall
Eli Lilly and Co. and a development partner has canceled clinical trials on an experimental drug to treat multiple sclerosis after the drug failed to delay progression of the disease in trial patients.
More

Potential obesity breakthrough boosts Marcadia

July 20, 2009
J.K. Wall
Favorable article in prestigious journal could draw attention to Carmel biotech startup.
More

Drug industry funds Democrat-led panel on health care reformRestricted Content

July 20, 2009
J.K. Wall
The pharmaceutical industry—which for two decades has given twice as much in campaign donations to Republicans as Democrats—organized a panel composed mostly of Democrats this month in Indianapolis to argue its position on health care reform.
More

Endocyte, Purdue develop prostate cancer treatment device

July 13, 2009
 IBJ Staff
Purdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed a prostate cancer “homing device” to help anti-cancer agents specifically target prostate cancer tumors.

More

Profs trying to revolutionize drug discovery processRestricted Content

June 22, 2009
 IBJ Staff
Two chemistry professors at IUPUI are laboring to create the McDonald's of research laboratories—a model that's low-cost and can spread around the world.
More

With Byetta's sales stalled, Lilly unveils its own competitorRestricted Content

June 15, 2009
 IBJ Staff
While Eli Lilly and Co. continues to work with a biotech firm on the diabetes medicine Byetta, it's developing a potential competitor to Byetta all on its own.
More

Biotechnology firm boosts its protein bizRestricted Content

June 8, 2009
 IBJ Staff
Greenwood-based Elona Biotechnologies said it has created two subsidiaries to boost its biosimilar/biogeneric/follow-on protein business.
More

Commercializing science takes too long, Cook saysRestricted Content

May 25, 2009
Taking science from the laboratory to the commercial market takes too much time and is littered with potential pitfalls along the way.
More

Simple invention targets blanket problem for surgical patientsRestricted Content

May 25, 2009
Chris O'Malley
In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech, given that its latest product is nothing more than a warm blanket.
More

NFP of NOTE: Arthritis Foundation Indiana chapter

April 20, 2009
The Indiana chapter of the Arthritis Foundation works to improve lives through leadership in the prevention, control and cure of arthritis and related diseases.
More

Indiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individualsRestricted Content

April 13, 2009
Chris O'Malley
Indiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to use it on the practitioner level.
More

Purdue student venture fund invests in Kylin TherapeuticsRestricted Content

March 16, 2009
Purdue University's Student-Managed Venture Fund is betting its bank on West Lafayette-based biotech startup Kylin Therapeutics Inc.
More

Health care IT firms rushing to grab share of stimulusRestricted Content

March 9, 2009
J.K. Wall
The stimulus bill has prompted Indiana businesses and not-for-profits that deal in medical records to look for partners to help them meet the challenge of making those records electronic in five years.
More

AIT Laboratories named 'Small Business of the Year'Restricted Content

March 2, 2009
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009 Small Business of the Year.
More

3M prepares launch of Hoosier startup's toothpasteRestricted Content

December 22, 2008
Peter Schnitzler
In January, St. Paul, Minn.-based 3M will release "Clinpro 5000," a specialty toothpaste Indiana Nanotech developed.
More

'Smoke free' needs to be the law in all Hoosier public placesRestricted Content

December 15, 2008
If Indianapolis is going to be a first-class city, it needs to have a comprehensive smoke-free workplace law.
More

Dry cleaner's fight against sons' rare disease could lead to other life-saving treatmentsRestricted Content

July 21, 2008
Anthony Schoettle
Nathan's Battle Foundation, led by Phil Milto--who has two sons afflicted with the disease--has evolved over 10 years into what Milto calls a not-for-profit biotech company that has raised money and guided research that resulted in a promising treatment for Batten disease. Now, some of the gene therapy techniques researchers developed are being applied to other disorders.
More

IU takes statewide approach to life sciences pitchRestricted Content

January 21, 2008
J.K. Wall
For the last two months, two academics at Indiana University and Purdue University have been discussing how the institutions can work together to rev up research in medicine and life sciences and, in the process, boost Indiana's economy.
More

Surgeon helping pioneer efforts to regrow knee cartilageRestricted Content

March 26, 2007
J.K. Wall
When Dr. Jack Farr II saw his grandfather's knees become bowed out, then saw his father get a knee replacement, he knew he was next. So he spent his career trying to develop new techniques to replace--and now even regrow--the cartilage around knees. His labors are part of an international effort to develop alternatives to joint replacements.
More
Page  << 1 2 3 4 pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. With Pence running the ship good luck with a new government building on the site. He does everything on the cheap except unnecessary roads line a new beltway( like we need that). Things like state of the art office buildings and light rail will never be seen as an asset to these types. They don't get that these are the things that help a city prosper.

  2. Does the $100,000,000,000 include salaries for members of Congress?

  3. "But that doesn't change how the piece plays to most of the people who will see it." If it stands out so little during the day as you seem to suggest maybe most of the people who actually see it will be those present when it is dark enough to experience its full effects.

  4. That's the mentality of most retail marketers. In this case Leo was asked to build the brand. HHG then had a bad sales quarter and rather than stay the course, now want to go back to the schlock that Zimmerman provides (at a considerable cut in price.) And while HHG salesmen are, by far, the pushiest salesmen I have ever experienced, I believe they are NOT paid on commission. But that doesn't mean they aren't trained to be aggressive.

  5. The reason HHG's sales team hits you from the moment you walk through the door is the same reason car salesmen do the same thing: Commission. HHG's folks are paid by commission they and need to hit sales targets or get cut, while BB does not. The sales figures are aggressive, so turnover rate is high. Electronics are the largest commission earners along with non-needed warranties, service plans etc, known in the industry as 'cheese'. The wholesale base price is listed on the cryptic price tag in the string of numbers near the bar code. Know how to decipher it and you get things at cost, with little to no commission to the sales persons. Whether or not this is fair, is more of a moral question than a financial one.

ADVERTISEMENT